Abstract
Stem cell-based therapeutics is a rapidly developing field associated with a number of clinical challenges. One such challenge lies in the implementation of methods to track stem cells and stem cell-derived cells in experimental animal models and in the living patient. Here, we provide an overview of cell tracking in the context of cardiac and neurological disease, focusing on the use of iron oxide-based particles (IOPs) visualized in vivo using magnetic resonance imaging (MRI). We discuss the types of IOPs available for such tracking, their advantages and limitations, approaches for labeling cells with IOPs, biological interactions and effects of IOPs at the molecular and cellular levels, and MRI-based and associated approaches for in vivo and histological visualization. We conclude with reviews of the literature on IOP-based cell tracking in cardiac and neurological disease, covering both preclinical and clinical studies.
Similar content being viewed by others
Change history
15 June 2021
A Correction to this paper has been published: https://doi.org/10.1007/s11307-021-01590-4
References
Uygur A, Lee RT (2016) Mechanisms of cardiac regeneration. Dev Cell 36:362–374
Winner B, Winkler J (2015) Adult neurogenesis in neurodegenerative diseases. Cold Spring Harb Perspect Biol 7:a021287
Tuszynski MH, Wang Y, Graham L et al (2014) Neural stem cells in models of spinal cord injury. Exp Neurol 261:494–500
Rafatian G, Davis DR (2018) Concise review: heart-derived cell therapy 2.0: paracrine strategies to increase therapeutic repair of injured myocardium. Stem Cells 36:1794–1803
Aarntzen EH, Srinivas M, Walczak P et al (2012) In vivo tracking techniques for cellular regeneration, replacement, and redirection. J Nucl Med 53:1825–1828
Srivastava AK, Bulte JW (2014) Seeing stem cells at work in vivo. Stem Cell 10:127–144
Cromer Berman SM, Walczak P, Bulte JW (2011) Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3:343–355
Contag CH, Bachmann MH (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4:235–260
Helmchen F, Denk W (2005) Deep tissue two-photon microscopy. Nat Methods 2:932–940
Jacobs RE, Cherry SR (2001) Complementary emerging techniques: high-resolution PET and MRI. Curr Opin Neurobiol 11:621–629
de Kemp RA, Epstein FH, Catana C et al (2010) Small-animal molecular imaging methods. J Nucl Med 51 Suppl 1:18s–32s
Long CM, Bulte JW (2009) In vivo tracking of cellular therapeutics using magnetic resonance imaging. Expert Opin Biol Ther 9:293–306
Li SC, Tachiki LM, Luo J et al (2010) A biological global positioning system: considerations for tracking stem cell behaviors in the whole body. Stem Cell Rev 6:317–333
Hoehn M, Kustermann E, Blunk J et al (2002) Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 99:16267–16272
Wen X, Wang Y, Zhang F et al (2014) In vivo monitoring of neural stem cells after transplantation in acute cerebral infarction with dual-modal MR imaging and optical imaging. Biomaterials 35:4627–4635
Modo M, Beech JS, Meade TJ et al (2009) A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage 47(Suppl 2):T133–T142
Modo M, Mellodew K, Cash D et al (2004) Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 21:311–317
Lee JH, Huh YM, Jun YW et al (2007) Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13:95–99
Shen T, Weissleder R, Papisov M et al (1993) Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 29:599–604
Heyn C, Ronald JA, Ramadan SS et al (2006) In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med 56:1001–1010
Shapiro EM, Sharer K, Skrtic S, Koretsky AP (2006) In vivo detection of single cells by MRI. Magn Reson Med 55:242–249
Shubayev VI, Pisanic TR 2nd, Jin S (2009) Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61:467–477
Masserini (2013) Nanoparticles for brain drug delivery. ISRN Biochem 2013:238428
Nkansah MK, Thakral D, Shapiro EM (2011) Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking. Magn Reson Med 65:1776–1785
Shapiro EM (2015) Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking. Magn Reson Med 73:376–389
De Cuyper M, Joniau M (1988) Magnetoliposomes. Formation and structural characterization. Eur Biophys J 15:311–319
Monnier CA BD, Rothen-Rutishauer B, Lattuada M, Petri-Fink A (2014) Magnetoliposomes: opportunities and challenges. Eur J Nanomed 6. doi https://doi.org/10.1515/ejnm-2014-0042.
Barrow M, Taylor A, Murray P et al (2015) Design considerations for the synthesis of polymer coated iron oxide nanoparticles for stem cell labelling and tracking using MRI. Chem Soc Rev 44:6733–6748
Yeh TC, Zhang W, Ildstad ST, Ho C (1993) Intracellular labeling of T-cells with superparamagnetic contrast agents. Magn Reson Med 30:617–625
Yeh TC, Zhang W, Ildstad ST, Ho C (1995) In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn Reson Med 33:200–208
Lojk J, Bregar VB, Rajh M et al (2015) Cell type-specific response to high intracellular loading of polyacrylic acid-coated magnetic nanoparticles. Int J Nanomedicine 10:1449–1462
Josephson L, Tung CH, Moore A, Weissleder R (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10:186–191
Lewin M, Carlesso N, Tung CH et al (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18:410–414
Kraitchman DL, Heldman AW, Atalar E et al (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:2290–2293
Frank JA, Miller BR, Arbab AS et al (2003) Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228:480–487
Arbab AS, Bashaw LA, Miller BR et al (2003) Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 76:1123–1130
Arbab AS, Yocum GT, Kalish H et al (2004) Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217–1223
Thu MS, Najbauer J, Kendall SE et al (2009) Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS One 4:e7218
Kustermann E, Himmelreich U, Kandal K et al (2008) Efficient stem cell labeling for MRI studies. Contrast Media Mol Imaging 3:27–37
Walczak P, Kedziorek DA, Gilad AA et al (2005) Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 54:769–774
Walczak P, Ruiz-Cabello J, Kedziorek DA et al (2006) Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. Nanomedicine 2:89–94
Qiu B, Xie D, Walczak P et al (2010) Magnetosonoporation: instant magnetic labeling of stem cells. Magn Reson Med 63:1437–1441
Xie D, Qiu B, Walczak P et al (2010) Optimization of magnetosonoporation for stem cell labeling. NMR Biomed 23:480–484
Bulte JW, Zhang S, van Gelderen P et al (1999) Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 96:15256–15261
Ahrens ET, Feili-Hariri M, Xu H et al (2003) Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 49:1006–1013
Shapiro EM, Medford-Davis LN, Fahmy TM et al (2007) Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI. Contrast Media Mol Imaging 2:147–153
Hill JM, Dick AJ, Raman VK et al (2003) Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 108:1009–1014
Arbab AS, Yocum GT, Rad AM et al (2005) Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 18:553–559
Boulland JL, Leung DS, Thuen M et al (2012) Evaluation of intracellular labeling with micron-sized particles of iron oxide (MPIOs) as a general tool for in vitro and in vivo tracking of human stem and progenitor cells. Cell Transplant 21:1743–1759
Detante O, Valable S, de Fraipont F et al (2012) Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype: study in a rat model of stroke. Stem Cells Transl Med 1:333–341
Shen WB, Plachez C, Chan A et al (2013) Human neural progenitor cells retain viability, phenotype, proliferation, and lineage differentiation when labeled with a novel iron oxide nanoparticle, Molday ION Rhodamine B. Int J Nanomedicine 8:4593–4600
Kostura L, Kraitchman DL, Mackay AM et al (2004) Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 17:513–517
Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF (2004) Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood 104:3410–3412 author reply 3412-3
Chen YC, Hsiao JK, Liu HM et al (2010) The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells. Toxicol Appl Pharmacol 245:272–279
Nohroudi K, Arnhold S, Berhorn T et al (2010) In vivo MRI stem cell tracking requires balancing of detection limit and cell viability. Cell Transplant 19:431–441
Bulte JW, Douglas T, Witwer B et al (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19:1141–1147
Cohen ME, Muja N, Fainstein N et al (2010) Conserved fate and function of ferumoxides-labeled neural precursor cells in vitro and in vivo. J Neurosci Res 88:936–944
Guzman R, Uchida N, Bliss TM et al (2007) Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A 104:10211–10216
Focke A, Schwarz S, Foerschler A et al (2008) Labeling of human neural precursor cells using ferromagnetic nanoparticles. Magn Reson Med 60:1321–1328
Ramos-Gomez M, Seiz EG, Martinez-Serrano A (2015) Optimization of the magnetic labeling of human neural stem cells and MRI visualization in the hemiparkinsonian rat brain. J Nanobiotechnol 13:20
Goodfellow F, Simchick GA, Mortensen LJ et al (2016) Tracking and quantification of magnetically labeled stem cells using magnetic resonance imaging. Adv Funct Mater 26:3899–3915
Au KW, Liao SY, Lee YK et al (2009) Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells. Biochem Biophys Res Commun 379:898–903
Wang YX (2011) Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg 1:35–40
Tu C, Ng TS, Sohi HK et al (2011) Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques. Biomaterials 32:7209–7216
McAteer MA, Schneider JE, Ali ZA et al (2008) Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol 28:77–83
Argibay B, Trekker J, Himmelreich U et al (2017) Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia. Sci Rep 7:40758
Saiyed ZM, Gandhi NH, Nair MP (2010) Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier. Int J Nanomedicine 5:157–166
Yuan ZY, Hu YL, Gao JQ (2015) Brain localization and neurotoxicity evaluation of polysorbate 80-modified chitosan nanoparticles in rats. PLoS One 10:e0134722
Kong SD, Lee J, Ramachandran S et al (2012) Magnetic targeting of nanoparticles across the intact blood-brain barrier. J Control Release 164:49–57
Thomsen LB, Linemann T, Pondman KM et al (2013) Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells. ACS Chem Neurosci 4:1352–1360
Busquets MA, Espargaro A, Sabate R, Estelrich J (2015) Magnetic nanoparticles cross the blood-brain barrier: when physics rises to a challenge. Nanomaterials 5:2231–2248
Yarjanli Z, Ghaedi K, Esmaeili A et al (2017) Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci 18:51
Cengelli F, Maysinger D, Tschudi-Monnet F et al (2006) Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther 318:108–116
Imam SZ, Lantz-McPeak SM, Cuevas E et al (2015) Iron oxide nanoparticles induce dopaminergic damage: in vitro pathways and in vivo imaging reveals mechanism of neuronal damage. Mol Neurobiol 52:913–926
Desestret V, Brisset JC, Moucharrafie S et al (2009) Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice. Stroke 40:1834–1841
Chang J, Jallouli Y, Kroubi M et al (2009) Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. Int J Pharm 379:285–292
Qiao R, Jia Q, Huwel S et al (2012) Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano 6:3304–3310
Wang B, Feng WY, Wang M et al (2007) Transport of intranasally instilled fine Fe2O3 particles into the brain: micro-distribution, chemical states, and histopathological observation. Biol Trace Elem Res 118:233–243
Wang B, Wang Q, Chen H et al (2016) Size-dependent translocation pattern, chemical and biological transformation of nano- and submicron-sized ferric oxide particles in the central nervous system. J Nanosci Nanotechnol 16:5553–5561
Suarez S, Almutairi A, Christman K (2015) Micro- and nanoparticles for treating cardiovascular disease. Biomater Sci 3:564–580
Chen J, Yang J, Liu R et al (2017) Dual-targeting theranostic system with mimicking apoptosis to promote myocardial infarction repair via modulation of macrophages. Theranostics 7:4149–4167
Terrovitis JV, Smith RR, Marban E (2010) Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 106:479–494
Zhu J, Zhou L, XingWu F (2006) Tracking neural stem cells in patients with brain trauma. N Engl J Med 355:2376–2378
Afridi MJ, Ross A, Liu X et al (2017) Intelligent and automatic in vivo detection and quantification of transplanted cells in MRI. Magn Reson Med 78:1991–2002
Bulte JW, Walczak P, Janowski M et al (2015) Quantitative “hot spot” imaging of transplanted stem cells using superparamagnetic tracers and magnetic particle imaging (MPI). Tomography 1:91–97
van den Bos EJ, Baks T, Moelker AD et al (2006) Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking? Eur Heart J 27:1620–1626
Amsalem Y, Mardor Y, Feinberg MS et al (2007) Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 116(Suppl):I38–I45
Zheng B, von See MP, Yu E et al (2016) Quantitative magnetic particle imaging monitors the transplantation, biodistribution, and clearance of stem cells in vivo. Theranostics 6:291–301
Hainfeld J, Slatkin D, Focella T, Smilowitz H (2006) Gold nanoparticles: a new x-ray contrast agent. Br J Radiol 79:248–253
Farini A, Villa C, Manescu A et al (2012) Novel insight into stem cell trafficking in dystrophic muscle. Int J Nanomed 7:3059–3067
Torrente Y, Gavina M, Belicchi M et al (2006) High resolution X-ray microtomography for three-dimensional visualization of human stem cell muclse homing. FEBS Letters 580:5759–5764
Albers J, Pacilé S, Markus M et al (2018) X-ray-based 3D virtual histology - adding the next dimension to histological analsysis. Mole Imaging Biol 20:732–741
Kinney JH, Nichols MC (1992) X-ray tomographic microscopy (XTM) using synchrotron radiation. Ann Rev Mater Sci 22:121–152
Withers PJ (2007) X.ray nanotomography. Materials Today 10:26–34
Marinescu M, Langer M, Durand A et al (2013) Synchrotron radiation x-ray phase microcomputed tomography as a new method to detect iron oxide nanoparticles in the brain. Mol Imaging Biol 15:552–559
Scharlach C, Muller L, Wagner S et al (2016) LA-ICP-MS allows quantitative microscopy of europium-doped iron oxide nanoparticles and is a possible alternative to ambiguous prussian blue iron staining. J Biomed Nanotechnol 12:1001–1010
Sumner JP, Conroy R, Shapiro EM et al (2007) Delivery of fluorescent probes using iron oxide particles as carriers enables in-vivo labeling of migrating neural precursors for magnetic resonance imaging and optical imaging. J Biomed Opt 12:051504
Shen TT, Bogdanov A Jr, Bogdanova A, Pet al. (1996) Magnetically labeled secretin retains receptor affinity to pancreas acinar cells. Bioconjug Chem 7:311–316
De Palma R, Trekker J, Peeters S et al (2007) Surface modification of gamma-Fe2O3@SiO2 magnetic nanoparticles for the controlled interaction with biomolecules. J Nanosci Nanotechnol 7:4626–4641
Amstad E, Zurcher S, Mashaghi A et al (2009) Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging. Small 5:1334–1342
Wei H, Insin N, Lee J et al (2012) Compact zwitterion-coated iron oxide nanoparticles for biological applications. Nano Lett 12:22–25
Yang T, Sun S, Ma M et al (2015) Optimizing immobilization of avidin on surface-modified magnetic nanoparticles: characterization and application of protein-immobilized nanoparticles. Bioprocess Biosyst Eng 38:2023–2034
Odintsov B, Chun JL, Berry SE (2013) Whole body MRI and fluorescent microscopy for detection of stem cells labeled with superparamagnetic iron oxide (SPIO) nanoparticles and DiI following intramuscular and systemic delivery. Methods Mol Biol 1052:177–193
Markides H, Kehoe O, Morris RH, El Haj AJ (2013) Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells--a rheumatoid arthritis mouse model. Stem Cell Res Ther 4:126
Rossini A, Frati C, Lagrasta C et al (2011) Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin. Cardiovasc Res 89:650–660
Glover JC (1995) Retrograde and anterograde axonal tracing with fluorescent dextrans in the embryonic nervous system. Neurosci Protocols 30:1–13
Glover JC (2014) Conjugated dextran amines as intracellular tracers for visualizing and manipulating neurons. In: FG P (ed) Dextran: chemical structure, applications and potential side effects. Recent trends in biotechnology. Nova Publishers, Hauppauge, pp 157–174
Aggarwal P, Hall JB, McLeland CB et al (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61:428–437
Treuel L, Docter D, Maskos M, Stauber RH (2015) Protein corona - from molecular adsorption to physiological complexity. Beilstein J Nanotechnol 6:857–873
Safi M, Courtois J, Seigneuret M et al (2011) The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 32:9353–9363
Pavlin M, Bregar VB (2012) Stability of nanoparticle suspensions in different biologically relevant media. Dig J Nanomater Bios 7:1389–1400
Tenzer S, Docter D, Kuharev J et al (2013) Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 8:772–781
Strojan K, Leonardi A, Bregar VB et al (2017) Dispersion of nanoparticles in different media importantly determines the composition of their protein corona. PLoS One 12:e0169552
Chen F, Wang G, Griffin JI et al (2017) Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nat Nanotechnol 12:387–393
Lundqvist M, Stigler J, Elia G et al (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 105:14265–14270
Deng ZJ, Liang M, Monteiro M et al (2011) Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol 6:39–44
Iversen T-G, Skotland T, Sandvig K (2011) Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. NanoToday 6:176–185
Kuhn DA, Vanhecke D, Michen B et al (2014) Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein J Nanotechnol 5:1625–1636
Akinc A, Battaglia G (2013) Exploiting endocytosis for nanomedicines. Cold Spring Harb Perspect Biol 5:a016980
Ali LM, Pinol R, Villa-Bellosta R et al (2015) Cell compatibility of a maghemite/polymer biomedical nanoplatform. Toxicol In Vitro 29:962–975
Petters C, Bulcke F, Thiel K et al (2014) Uptake of fluorescent iron oxide nanoparticles by oligodendroglial OLN-93 cells. Neurochem Res 39:372–383
Petters C, Dringen R (2015) Accumulation of iron oxide nanoparticles by cultured primary neurons. Neurochem Int 81:1–9
Bareford LM, Swaan PW (2007) Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59:748–758
Freeman SA, Grinstein S (2014) Phagocytosis: receptors, signal integration, and the cytoskeleton. Immunol Rev 262:193–215
Liu D, Wu W, Ling J et al (2011) Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging. Adv Funct Mater 21:1498–1504
Ni F, Jiang L, Yang R et al (2012) Effects of PEG length and iron oxide nanoparticles size on reduced protein adsorption and non-specific uptake by macrophage cells. J Nanosci Nanotechnol 12:2094–2100
Bobo D, Robinson KJ, Islam J et al (2016) Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res 33:2373–2387
Moghimi SM, Andersen AJ, Hashemi SH et al (2010) Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead. J Control Release 146:175–181
Szebeni J, Baranyi L, Savay S et al (2006) Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function. Am J Physiol Heart Circ Physiol 290:H1050–H1058
Andersen AJ, Windschiegl B, Ilbasmis-Tamer S et al (2013) Complement activation by PEG-functionalized multi-walled carbon nanotubes is independent of PEG molecular mass and surface density. Nanomedicine 9:469–473
Banda NK, Mehta G, Chao Y et al (2014) Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum. Part Fibre Toxicol 11:64
Wang G, Chen F, Banda NK et al (2016) Activation of human complement system by dextran-coated iron oxide nanoparticles is not affected by dextran/Fe ratio, hydroxyl modifications, and crosslinking. Front Immunol 7:418
Wolf-Grosse S, Rokstad AM, Ali S et al (2017) Iron oxide nanoparticles induce cytokine secretion in a complement-dependent manner in a human whole blood model. Int J Nanomed 12:3927–3940
Cengelli F, Voinesco F, Juillerat-Jeanneret L (2010) Interaction of cationic ultrasmall superparamagnetic iron oxide nanoparticles with human melanoma cells. Nanomedicine 5:1075–1087
Wu X, Tan Y, Mao H, Zhang M (2010) Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int J Nanomedicine 5:385–399
Geppert M, Hohnholt MC, Thiel K et al (2011) Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 22:145101
Kumar M, Singh G, Arora V et al (2012) Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. Int J Nanomed 7:3503–3516
Zhang X, Zhang H, Liang X et al (2016) Iron oxide nanoparticles induce autophagosome accumulation through multiple mechanisms: lysosome impairment, mitochondrial damage, and ER stress. Mol Pharm 13:2578–2587
Bregar VB, Lojk J, Sustar V et al (2013) Visualization of internalization of functionalized cobalt ferrite nanoparticles and their intracellular fate. Int J Nanomedicine 8:919–931
Ndong C, Tate JA, Kett WC et al (2015) Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo. PLoS One 10:e0115636
Arbab AS, Wilson LB, Ashari P et al (2005) A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed 18:383–389
Levy M, Lagarde F, Maraloiu VA et al (2010) Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties. Nanotechnology 21:395103
Soenen SJ, Himmelreich U, Nuytten N et al (2010) Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small 6:2136–2145
Malvindi MA, De Matteis V, Galeone A et al (2014) Toxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineering. PLoS One 9:e85835
Sabella S, Carney RP, Brunetti V et al (2014) A general mechanism for intracellular toxicity of metal-containing nanoparticles. Nanoscale 6:7052–7061
Gutierrez L, Romero S, da Silva GB et al (2015) Degradation of magnetic nanoparticles mimicking lysosomal conditions followed by AC susceptibility. Biomed Tech 60:417–425
Volatron J, Carn F, Kolosnjaj-Tabi J, et al. (2017) Ferritin protein regulates the degradation of iron oxide nanoparticles. Small 13. doi https://doi.org/10.1002/smll.201602030
Weissleder R, Stark DD, Engelstad BL et al (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 152:167–173
Pouliquen D, Le Jeune JJ, Perdrisot R et al (1991) Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn Reson Imaging 9:275–283
Sakhtianchi R, Minchin RF, Lee KB et al (2013) Exocytosis of nanoparticles from cells: role in cellular retention and toxicity. Adv Colloid Interface Sci 201-202:18–29
Parton RG, del Pozo MA (2013) Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 14:98–112
Kafshgari MH, Harding FJ, Voelcker NH (2015) Insights into cellular uptake of nanoparticles. Curr Drug Deliv 12:63–77
Wu H, Yin JJ, Wamer WG et al (2014) Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides. J Food Drug Anal 22:86–94
Hohnholt MC, Dringen R (2011) Iron-dependent formation of reactive oxygen species and glutathione depletion after accumulation of magnetic iron oxide nanoparticles by oligodendroglial cells. J Nanopart Res 13:6761–6774
Lunov O, Syrovets T, Rocker C et al (2010) Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials 31:9015–9022
Laskar A, Ghosh M, Khattak SI, Li W, Yuan XM (2012) Degradation of superparamagnetic iron oxide nanoparticle-induced ferritin by lysosomal cathepsins and related immune response. Nanomedicine 7:705–717
Munoz Y, Carrasco CM, Campos JD, et al. (2016) Parkinson’s disease: the mitochondria-iron link. Parkinsons Dis 2016. doi: https://doi.org/10.1155/2016/7049108
Nunez MT, Urrutia P, Mena N et al (2012) Iron toxicity in neurodegeneration. Biometals 25:761–776
Park EJ, Choi DH, Kim Y et al (2014) Magnetic iron oxide nanoparticles induce autophagy preceding apoptosis through mitochondrial damage and ER stress in RAW264.7 cells. Toxicol In Vitro 28:1402–1412
Soenen SJ, Nuytten N, De Meyer SF et al (2010) High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling. Small 6:832–842
Soenen SJ, Himmelreich U, Nuytten N, De Cuyper M (2011) Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 32:195–205
Diana V, Bossolasco P, Moscatelli D et al (2013) Dose dependent side effect of superparamagnetic iron oxide nanoparticle labeling on cell motility in two fetal stem cell populations. PLoS One 8:e78435
Pongrac IM, Pavicic I, Milic M et al (2016) Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles. Int J Nanomed 11:1701–1715
Kehrer JP (2000) The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 149:43–50
Geppert M, Hohnholt MC, Nurnberger S, Dringen R (2012) Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater 8:3832–3839
Uttara B, Singh AV, Zamboni P, Mahajan RT (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7:65–74
Urrutia PJ, Mena NP, Nunez MT (2014) The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders. Front Pharmacol 5:38
Liu G, Men P, Perry G, Smith MA (2010) Nanoparticle and iron chelators as a potential novel Alzheimer therapy. Methods Mol Biol 610:123–144
Mochizuki H, Yasuda T (2012) Iron accumulation in Parkinson’s disease. J Neural Transm 119:1511–1514
Ayton S, Lei P (2014) Nigral iron elevation is an invariable feature of Parkinson’s disease and is a sufficient cause of neurodegeneration. Biomed Res Int 2014:581256
Eschenhagen T, Bolli R, Braun T et al (2017) Cardiomyocyte regeneration: a consensus statement. Circulation 136:680–686
Gyöngyösi M, Haller PM, Blake DJ, Martin Rendon E (2018) meta-analysis of cell therapy studies in heart failure and acute myocardial infarction. Circ Res 123:301–308
Tateishi-Yuyama E, Matsubara H, Murohara T et al (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360:427–435
Higashi Y, Kimura M, Hara K et al (2004) Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 109:1215–1218
Huang PP, Li SZ, Han MZ et al (2004) Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost 91:606–609
Emani SM, Del Nido PJ (2018) Cell-based therapy with cardiosphere-derived cardiocytes: a new hope for pediatric patients with single ventricle congenital heart disease? Circ Res 122:916–917
Gerber TC, Carr JJ, Arai AE et al (2009) Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation 119:1056–1065
Luo L, Nishi K, Urata Y et al (2017) Ionizing radiation impairs endogenous regeneration of infarcted heart: an in vivo 18F-FDG PET/CT and 99mTc-tetrofosmin SPECT/CT study in mice. Radiat Res 187:89–97
Himes N, Min JY, Lee R et al (2004) In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med 52:1214–1219
Arai T, Kofidis T, Bulte JW et al (2006) Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 t. Magn Reson Med 55:203–209
Mani V, Adler E, Briley-Saebo KC et al (2008) Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn Reson Med 60:73–81
Amado LC, Saliaris AP, Schuleri KH et al (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102:11474–11479
Terrovitis J, Stuber M, Youssef A et al (2008) Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 117:1555–1562
Richards JM, Shaw CA, Lang NN et al (2012) In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. Circ Cardiovasc Imaging 5:509–517
Lindvall O, Kokaia Z (2006) Stem cells for the treatment of neurological disorders. Nature 441:1094–1096
Naumova AV, Modo M, Moore A et al (2014) Clinical imaging in regenerative medicine. Nat Biotechnol 32:804–818
Hoehn M, Himmelreich U, Kruttwig K, Wiedermann D (2008) Molecular and cellular MR imaging: potentials and challenges for neurological applications. J Magn Reson Imaging 27:941–954
Neri M, Maderna C, Cavazzin C et al (2008) Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking. Stem Cells 26:505–516
Crabbe A, Vandeputte C, Dresselaers T et al (2010) Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant 19:919–936
Kallur T, Farr TD, Bohm-Sturm P et al (2011) Spatio-temporal dynamics, differentiation and viability of human neural stem cells after implantation into neonatal rat brain. Eur J Neurosci 34:382–393
Cromer Berman SM, Kshitiz, Wang CJ et al (2013) Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn Reson Med 69:255–262
Cianciaruso C, Pagani A, Martelli C et al (2014) Cellular magnetic resonance with iron oxide nanoparticles: long-term persistence of SPIO signal in the CNS after transplanted cell death. Nanomedicine 9:1457–1474
von der Haar K, Lavrentieva A, Stahl F et al (2015) Lost signature: progress and failures in in vivo tracking of implanted stem cells. Appl Microbiol Biotechnol 99:9907–9922
Ben-Hur T, van Heeswijk RB, Einstein O et al (2007) Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. Magn Reson Med 57:164–171
Jendelova P, Herynek V, DeCroos J et al (2003) Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med 50:767–776
Zhang Z, Jiang Q, Jiang F et al (2004) In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 23:281–287
Jones J, Estirado A, Redondo C et al (2015) Mesenchymal stem cells improve motor functions and decrease neurodegeneration in ataxic mice. Mol Ther 23:130–138
Andres RH, Horie N, Slikker W et al (2011) Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 134:1777–1789
Berman SC, Galpoththawela C, Gilad AA et al (2011) Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med 65:564–574
Frank JA, Kalish H, Jordan EK et al (2007) Color transformation and fluorescence of Prussian blue-positive cells: implications for histologic verification of cells labeled with superparamagnetic iron oxide nanoparticles. Mol Imaging 6:212–218
Jirakova K, Seneklova M, Jirak D et al (2016) The effect of magnetic nanoparticles on neuronal differentiation of induced pluripotent stem cell-derived neural precursors. Int J Nanomed 11:6267–6281
Lu LJ, Wang Y, Cao MH et al (2017) A novel polymeric micelle used for in vivo MR imaging tracking of neural stem cells in acute ischemic stroke. Rsc Advances 7:15041–15052
Aswendt M, Henn N, Michalk S et al (2015) Novel bimodal iron oxide particles for efficient tracking of human neural stem cells in vivo. Nanomedicine 10:2499–2512
Ramos-Gomez M, Martinez-Serrano A (2016) Tracking of iron-labeled human neural stem cells by magnetic resonance imaging in cell replacement therapy for Parkinson’s disease. Neural Regen Res 11:49–52
Himmelreich U, Weber R, Ramos-Cabrer P et al (2005) Improved stem cell MR detectability in animal models by modification of the inhalation gas. Mol Imaging 4:104–109
Cupaioli FA, Zucca FA, Boraschi D, Zecca L (2014) Engineered nanoparticles. How brain friendly is this new guest? Prog Neurobiol 119-120:20–38
Zheng B, Vazin T, Goodwill PW et al (2015) Magnetic particle imaging tracks the long-term fate of in vivo neural cell implants with high image contrast. Sci Rep 5:14055
Adamczak J, Aswendt M, Kreutzer C et al (2017) Neurogenesis upregulation on the healthy hemisphere after stroke enhances compensation for age-dependent decrease of basal neurogenesis. Neurobiol Dis 99:47–57
Adamczak J, Hoehn M (2015) Poststroke angiogenesis, con: dark side of angiogenesis. Stroke 46:e103–e104
Liu Z, Li Y, Zhang X et al (2008) Contralesional axonal remodeling of the corticospinal system in adult rats after stroke and bone marrow stromal cell treatment. Stroke 39:2571–2577
Ramos-Cabrer P, Hoehn M (2012) MRI stem cell tracking for therapy in experimental cerebral ischemia. Transl Stroke Res 3:22–35
Modo M, Hoehn M, Bulte JW (2005) Cellular MR imaging. Mol Imaging 4:143–164
Politi LS, Bacigaluppi M, Brambilla E et al (2007) Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis. Stem Cells 25:2583–2592
Muja N, Bulte JW (2009) Magnetic resonance imaging of cells in experimental disease models. Prog Nucl Magn Reson Spectrosc 55:61–77
Chaumeil MM, Gini B, Yang H et al (2012) Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla. Neuro Oncol 14:1050–1061
Elvira G, Garcia I, Benito M et al (2012) Live imaging of mouse endogenous neural progenitors migrating in response to an induced tumor. PLoS One 7:e44466
Karussis D, Karageorgiou C, Vaknin-Dembinsky A et al (2010) Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67:1187–1194
George PM, Steinberg GK (2015) Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments. Neuron 87:297–309
Steinberg GK, Kondziolka D, Wechsler LR et al (2016) Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1/2a study. Stroke 47:1817–1824
Janowski M, Walczak P, Kropiwnicki T et al (2014) Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF. PLoS One 9:e97631
Callera F, de Melo CM (2007) Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells’ migration into the injured site. Stem Cells Dev 16:461–466
Jin R, Lin B, Li D, Ai H (2014) Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 18:18–27
Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 101:10901–10906
Acknowledgments
All of the authors are members of the COST action 16122, Biomaterials and advanced physical techniques for regenerative cardiology and neurology (BIONECA), which has supported seminars and workshops that have served as the springboard for composing this review.
Funding
JCG and JLB are supported by the Norwegian Research Council (grants 230000, 189374, 229654) and the Southeastern Norway Health Authority (grants 2011035, 2015045, 2015102, 2014119). MP and JL are supported by ARRS grants J7-7424, Z4-8229 and P1-0055. DM is supported by the Croatian Science Foundation (IP-2016-06-9451) and co-financed by the European Union through the European Regional Development Fund, Operational Programme Competitiveness and Cohesion, grant agreement no. KK.01.1.1.01.0007, CoRE – Neuro.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article was updated to correct numerous mismatched references.
Rights and permissions
About this article
Cite this article
Glover, J.C., Aswendt, M., Boulland, JL. et al. In vivo Cell Tracking Using Non-invasive Imaging of Iron Oxide-Based Particles with Particular Relevance for Stem Cell-Based Treatments of Neurological and Cardiac Disease. Mol Imaging Biol 22, 1469–1488 (2020). https://doi.org/10.1007/s11307-019-01440-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-019-01440-4